{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:21:34Z","timestamp":1793110894327,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23zf0127003h"],"award-info":[{"award-number":["JP23zf0127003h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23gm1410013h"],"award-info":[{"award-number":["JP23gm1410013h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20gm5010001s"],"award-info":[{"award-number":["JP20gm5010001s"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ck010655h"],"award-info":[{"award-number":["JP20ck010655h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21gm6410014h"],"award-info":[{"award-number":["JP21gm6410014h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H00514"],"award-info":[{"award-number":["JP20H00514"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K21497"],"award-info":[{"award-number":["JP20K21497"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H05740"],"award-info":[{"award-number":["JP19H05740"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03431"],"award-info":[{"award-number":["JP19H03431"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H04940"],"award-info":[{"award-number":["JP20H04940"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-024-00704-1","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T10:05:03Z","timestamp":1725876303000},"page":"1582-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2179-5028","authenticated-orcid":false,"given":"Satoru","family":"Meguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-9607","authenticated-orcid":false,"given":"Yoshikazu","family":"Johmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satotaka","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki T.","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Kayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seira","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4249-3854","authenticated-orcid":false,"given":"Satoshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eigo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-8631","authenticated-orcid":false,"given":"Yoichi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-0868","authenticated-orcid":false,"given":"Yoshiyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-3584","authenticated-orcid":false,"given":"Makoto","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"704_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder cancer: a review. JAMA 324, 1980\u20131991 (2020).","journal-title":"JAMA"},{"key":"704_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1464-410X.2009.09076.x","volume":"105","author":"SF Shariat","year":"2010","unstructured":"Shariat, S. F. et al. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 105, 300\u2013308 (2010).","journal-title":"BJU Int."},{"key":"704_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"704_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer 20, 555\u2013572 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"704_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41698-019-0079-0","volume":"3","author":"H Takeshima","year":"2019","unstructured":"Takeshima, H. & Ushijima, T. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precis. Oncol. 3, 7 (2019).","journal-title":"NPJ Precis. Oncol."},{"key":"704_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/bjc.1975.242","volume":"32","author":"R Peto","year":"1975","unstructured":"Peto, R., Roe, F. J., Lee, P. N., Levy, L. & Clack, J. Cancer and ageing in mice and men. Br. J. Cancer 32, 411\u2013426 (1975).","journal-title":"Br. J. Cancer"},{"key":"704_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane, M. & Weeraratna, A. T. How the ageing microenvironment influences tumour progression. Nat. Rev. Cancer 20, 89\u2013106 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"704_CR8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"704_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"704_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen, X. & Song, E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat. Rev. Drug Discov. 18, 99\u2013115 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"704_CR11","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1084\/jem.20140692","volume":"211","author":"D \u00d6hlund","year":"2014","unstructured":"\u00d6hlund, D., Elyada, E. & Tuveson, D. Fibroblast heterogeneity in the cancer wound. J. Exp. Med. 211, 1503\u20131523 (2014).","journal-title":"J. Exp. Med."},{"key":"704_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi, G. & Tuveson, D. A. Diversity and biology of cancer-associated fibroblasts. Physiol. Rev. 101, 147\u2013176 (2021).","journal-title":"Physiol. Rev."},{"key":"704_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"704_CR14","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1200\/JCO.19.00861","volume":"37","author":"S Sadeghi","year":"2019","unstructured":"Sadeghi, S. et al. Phase II California cancer consortium trial of gemcitabine\u2013eribulin combination in cisplatin-ineligible patients with metastatic urothelial carcinoma: final report (NCI-9653). J. Clin. Oncol. 37, 2682\u20132688 (2019).","journal-title":"J. Clin. Oncol."},{"key":"704_CR15","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2018.4657","volume":"319","author":"EM Messing","year":"2018","unstructured":"Messing, E. M. et al. Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial. JAMA 319, 1880\u20131888 (2018).","journal-title":"JAMA"},{"key":"704_CR16","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796\u20132810 (2016).","journal-title":"Lancet"},{"key":"704_CR17","doi-asserted-by":"publisher","first-page":"108779","DOI":"10.1016\/j.celrep.2021.108779","volume":"34","author":"T Yasuda","year":"2021","unstructured":"Yasuda, T. et al. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. Cell Rep. 34, 108779 (2021).","journal-title":"Cell Rep."},{"key":"704_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cmet.2020.09.006","volume":"32","author":"S Omori","year":"2020","unstructured":"Omori, S. et al. Generation of a p16 reporter mouse and its use to characterize and target p16high cells in vivo. Cell Metab. 32, 814\u2013828 (2020).","journal-title":"Cell Metab."},{"key":"704_CR19","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363\u20139367 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"704_CR20","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN.2019040335","volume":"30","author":"Z Yu","year":"2019","unstructured":"Yu, Z. et al. Single-cell transcriptomic map of the human and mouse bladders. J. Am. Soc. Nephrol. 30, 2159\u20132176 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"704_CR21","doi-asserted-by":"publisher","first-page":"15208","DOI":"10.1038\/ncomms15208","volume":"8","author":"YH Kim","year":"2017","unstructured":"Kim, Y. H. et al. Senescent tumor cells lead the collective invasion in thyroid cancer. Nat. Commun. 8, 15208 (2017).","journal-title":"Nat. Commun."},{"key":"704_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12935-021-02314-y","volume":"21","author":"Y Du","year":"2021","unstructured":"Du, Y. et al. Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression. Cancer Cell Int. 21, 613 (2021).","journal-title":"Cancer Cell Int."},{"key":"704_CR23","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Gil, J. C., Martin-Hijano, L., Hermann, P. C. & Sainz, B.Jr. The CXCL12 crossroads in cancer stem cells and their niche. Cancers 13, 469 (2021).","DOI":"10.3390\/cancers13030469"},{"key":"704_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nmeth762","volume":"2","author":"T Buch","year":"2005","unstructured":"Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419\u2013426 (2005).","journal-title":"Nat. Methods"},{"key":"704_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78\u201383 (2016).","journal-title":"Nat. Med."},{"key":"704_CR26","first-page":"399","volume":"37","author":"M Nagao","year":"1977","unstructured":"Nagao, M., Suzuki, E., Yasuo, K., Yahagi, T. & Seino, Y. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds. Cancer Res. 37, 399\u2013407 (1977).","journal-title":"Cancer Res."},{"key":"704_CR27","first-page":"1969","volume":"63","author":"S Barbero","year":"2003","unstructured":"Barbero, S. et al. Stromal cell-derived factor 1\u03b1 stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1\/2 and Akt. Cancer Res. 63, 1969\u20131974 (2003).","journal-title":"Cancer Res."},{"key":"704_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1034\/j.1600-0609.2000.90112.x","volume":"64","author":"M Majka","year":"2000","unstructured":"Majka, M., Ratajczak, J., Kowalska, M. A. & Ratajczak, M. Z. Binding of stromal derived factor-1\u03b1 (SDF-1\u03b1) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42\/44 (MAPK), ELK-1 transcription factor and serine\/threonine kinase AKT. Eur. J. Haematol. 64, 164\u2013172 (2000).","journal-title":"Eur. J. Haematol."},{"key":"704_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000354132","volume":"40","author":"SP Fricker","year":"2013","unstructured":"Fricker, S. P. Physiology and pharmacology of plerixafor. Transfus. Med. Hemother. 40, 237\u2013245 (2013).","journal-title":"Transfus. Med. Hemother."},{"key":"704_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.trecan.2019.09.010","volume":"5","author":"BA Pereira","year":"2019","unstructured":"Pereira, B. A. et al. CAF subpopulations: a new reservoir of stromal targets in pancreatic cancer. Trends Cancer 5, 724\u2013741 (2019).","journal-title":"Trends Cancer"},{"key":"704_CR31","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat. Commun. 11, 5077 (2020).","journal-title":"Nat. Commun."},{"key":"704_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo, B., Zagorac, S., Corral, S., Marqu\u00e9s, M. & Real, F. X. Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities. Eur. Urol. Oncol. 6, 366\u2013375 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"704_CR33","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","volume":"8","author":"T Fulop","year":"2018","unstructured":"Fulop, T. et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front. Immunol. 8, 1960 (2018).","journal-title":"Front. Immunol."},{"key":"704_CR34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma, Z. et al. Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell 40, 1550\u20131565 (2022).","journal-title":"Cancer Cell"},{"key":"704_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.14336\/AD.2017.0103","volume":"8","author":"JR Aunan","year":"2017","unstructured":"Aunan, J. R., Cho, W. C. & S\u00f8reide, K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis. 8, 628\u2013642 (2017).","journal-title":"Aging Dis."},{"key":"704_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.14336\/AD.2016.1230","volume":"8","author":"A Zinger","year":"2017","unstructured":"Zinger, A., Cho, W. C. & Ben-Yehuda, A. Cancer and aging\u2014the inflammatory connection. Aging Dis. 8, 611\u2013627 (2017).","journal-title":"Aging Dis."},{"key":"704_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","volume":"21","author":"S Lee","year":"2019","unstructured":"Lee, S. & Schmitt, C. A. The dynamic nature of senescence in cancer. Nat. Cell Biol. 21, 94\u2013101 (2019).","journal-title":"Nat. Cell Biol."},{"key":"704_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2022.09.002","volume":"9","author":"Y Gabai","year":"2023","unstructured":"Gabai, Y., Assouline, B. & Ben-Porath, I. Senescent stromal cells: roles in the tumor microenvironment. Trends Cancer 9, 28\u201341 (2023).","journal-title":"Trends Cancer"},{"key":"704_CR39","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo, S. et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 39, 866\u2013882 (2021).","journal-title":"Cancer Cell"},{"key":"704_CR40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie, D., Ben-Shmuel, A., Erez, N. & Scherz-Shouval, R. Cancer-associated fibroblasts in the single-cell era. Nat. Cancer 3, 793\u2013807 (2022).","journal-title":"Nat. Cancer"},{"key":"704_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559\u2013572 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"704_CR42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"JA Witjes","year":"2017","unstructured":"Witjes, J. A. et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 71, 462\u2013475 (2017).","journal-title":"Eur. Urol."},{"key":"704_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1817323","volume":"381","author":"Y Loriot","year":"2019","unstructured":"Loriot, Y. et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N. Engl. J. Med. 381, 338\u2013348 (2019).","journal-title":"N. Engl. J. Med."},{"key":"704_CR44","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1200\/JCO.19.01140","volume":"37","author":"JE Rosenberg","year":"2019","unstructured":"Rosenberg, J. E. et al. Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1\/programmed death ligand 1 therapy. J. Clin. Oncol. 37, 2592\u20132600 (2019).","journal-title":"J. Clin. Oncol."},{"key":"704_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"704_CR46","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"704_CR47","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"704_CR48","doi-asserted-by":"publisher","first-page":"10574","DOI":"10.1038\/ncomms10574","volume":"7","author":"Y Johmura","year":"2016","unstructured":"Johmura, Y. et al. SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence. Nat. Commun. 7, 10574 (2016).","journal-title":"Nat. Commun."},{"key":"704_CR49","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020).","journal-title":"Nat. Biotechnol."},{"key":"704_CR50","doi-asserted-by":"publisher","first-page":"e0223178","DOI":"10.1371\/journal.pone.0223178","volume":"14","author":"T Watanabe","year":"2019","unstructured":"Watanabe, T. et al. Prediction of lymphovascular space invasion in endometrial cancer using the 55-gene signature selected by DNA microarray analysis. PLoS ONE 14, e0223178 (2019).","journal-title":"PLoS ONE"},{"key":"704_CR51","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","volume":"611","author":"T-W Wang","year":"2022","unstructured":"Wang, T.-W. et al. Blocking PD-L1\u2013PD-1 improves senescence surveillance and ageing phenotypes. Nature 611, 358\u2013364 (2022).","journal-title":"Nature"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00704-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00704-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00704-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T19:05:14Z","timestamp":1731611114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-024-00704-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1038\/s43587-024-00704-1","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.N. is a scientific advisor and shareholder at reverSASP Therapeutics. S.Y. is a co-founder of Celaid Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}